Asian Stock: Kalbe Farma

By Andrew Stotz of Become A Better Investor
Tuesday, November 1, 2022 2:09 AM EDT

Company: PT Kalbe Farma Tbk

Bloomberg ticker: KLBF IJ

Market cap: US$5,760m

Background: PT Kalbe Farma Tbk is an Indonesia-based pharmaceutical company. It manages an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drinks, and nutrition products, as well as a distribution arm serving more than 1m outlets. The company also operates in other ASEAN markets, Nigeria, and South Africa.


World Class Benchmarking of PT Kalbe Farma Tbk

(Click on image to enlarge)

  • Profitable Growth rank of 2 was up compared to the prior period’s 3rd rank
  • This is World Class performance compared to 380 large Health Care companies worldwide
  • Profitability rank of 2 was better than its Growth rank of 4
  • Profitability rank of 2 was the same compared to the prior period’s 2nd rank
  • This is World Class performance compared to peers
  • Growth rank of 4 was up compared to the prior period’s 6th rank
  • This is above-average performance compared to peers

More By This Author:

Asian Stock: Telkom Indonesia
Asian Stock: Airports Of Thailand
Asian Stock: Universal Robina

Disclaimer: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments